The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials.
about
The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The most prevalent side effect ...... tic review of clinical trials.
@en
The most prevalent side effect ...... tic review of clinical trials.
@nl
type
label
The most prevalent side effect ...... tic review of clinical trials.
@en
The most prevalent side effect ...... tic review of clinical trials.
@nl
prefLabel
The most prevalent side effect ...... tic review of clinical trials.
@en
The most prevalent side effect ...... tic review of clinical trials.
@nl
P2093
P2860
P356
P1433
P1476
The most prevalent side effect ...... tic review of clinical trials.
@en
P2093
A Sahebkar
F Shiehzadeh
S Nikoofal-Sahlabadi
Z Taherzadeh
P2860
P2888
P304
P356
10.1038/CGT.2017.9
P577
2017-04-14T00:00:00Z
P6179
1084851517